These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 16402218)
1. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen. Claus R; Hickstein H; Külz T; Lenschow U; Meiske D; Kotitschke A; Thiesen HJ; Lorenz P Rheumatol Int; 2006 Aug; 26(10):886-95. PubMed ID: 16402218 [TBL] [Abstract][Full Text] [Related]
2. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases]. Ayed K; Gorgi Y; Sfar I; Khrouf M Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933 [TBL] [Abstract][Full Text] [Related]
3. Neonatal lupus: bedside to bench and back. Buyon JP Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918 [TBL] [Abstract][Full Text] [Related]
4. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies. Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M Lupus; 2006; 15(6):346-53. PubMed ID: 16830880 [TBL] [Abstract][Full Text] [Related]
5. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block. Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310 [TBL] [Abstract][Full Text] [Related]
6. Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center. Doti PI; Escoda O; Cesar-Díaz S; Palasti S; Teixidó I; Sarquella-Brugada G; Gómez O; Martínez JM; Espinosa G Clin Rheumatol; 2016 Feb; 35(2):351-6. PubMed ID: 26791874 [TBL] [Abstract][Full Text] [Related]
7. [Neonatal lupus syndrome: Literature review]. Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481 [TBL] [Abstract][Full Text] [Related]
8. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block. Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327 [TBL] [Abstract][Full Text] [Related]
9. Ultrasound findings in fetal congenital heart block associated with maternal anti-Ro/SSA and Anti-La/SSB antibodies. Lai J; Clark TJ; Tan JH; Delaney S; Jolley JA Ultrasound Q; 2015 Mar; 31(1):34-6. PubMed ID: 25706362 [TBL] [Abstract][Full Text] [Related]
10. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block. Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723 [TBL] [Abstract][Full Text] [Related]
11. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block. Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164 [TBL] [Abstract][Full Text] [Related]
12. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block. Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891 [TBL] [Abstract][Full Text] [Related]
13. Specificity and effector mechanisms of autoantibodies in congenital heart block. Wahren-Herlenius M; Sonesson SE Curr Opin Immunol; 2006 Dec; 18(6):690-6. PubMed ID: 17011766 [TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Saleeb S; Copel J; Friedman D; Buyon JP Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block. Ivanchenko M; Thorlacius GE; Hedlund M; Ottosson V; Meneghel L; Björkander S; Ossoinak A; Tingström J; Bremme K; Sverremark-Ekström E; Gemzell-Danielsson K; Sonesson SE; Chemin K; Wahren-Herlenius M Ann Rheum Dis; 2021 Feb; 80(2):194-202. PubMed ID: 33004330 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune-mediated congenital heart block. Wainwright B; Bhan R; Trad C; Cohen R; Saxena A; Buyon J; Izmirly P Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():41-51. PubMed ID: 31685414 [TBL] [Abstract][Full Text] [Related]
17. Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases. Fredi M; Argolini LM; Angeli F; Trespidi L; Ramoni V; Zatti S; Vojinovic T; Donzelli D; Gazzola FG; Xoxi B; Andreoli L; Lojacono A; Ferrazzi E; Montecucco C; Chighizola CB; Meroni PL; Franceschini F; Cimaz R; Caporali R; Tincani A; Gerosa M Clin Exp Rheumatol; 2023 Mar; 41(3):685-693. PubMed ID: 36377571 [TBL] [Abstract][Full Text] [Related]
18. Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block. Tonello M; Ruffatti A; Marson P; Tison T; Marozio L; Hoxha A; De Silvestro G; Punzi L Transfusion; 2015 Jul; 55(7):1782-6. PubMed ID: 25825254 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study. Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240 [TBL] [Abstract][Full Text] [Related]
20. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. Miranda ME; Tseng CE; Rashbaum W; Ochs RL; Casiano CA; Di Donato F; Chan EK; Buyon JP J Immunol; 1998 Nov; 161(9):5061-9. PubMed ID: 9794444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]